Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Muscular Atrophy × Exercise × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 246 Breast Neoplasms 135 Neoplasms 107 Prostatic Neoplasms 35 Fatigue 35 Obesity 25 Colorectal Neoplasms 24 Lung Neoplasms 21 Polycystic Ovary Syndrome 17 Colonic Neoplasms 15 Ovarian Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma 11 Lymphedema 11 Hematologic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Pancreatic Neoplasms 10 Multiple Myeloma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Leukemia 9 Cardiotoxicity 9 Insulin Resistance 8 Brain Neoplasms 8 Stomach Neoplasms 6 Peripheral Nervous System Diseases 6 Overweight 6 Cognitive Dysfunction 6 Cachexia 6

Interventions

ostarine 3 rimabotulinumtoxinB 1 Standard of Care 1 Olanzapine 1 Exercise 1 Enteral Nutrition 1 Electric Stimulation 1 Eicosapentaenoic Acid 1 Diet Therapy 1 Cyproheptadine 1 Creatine 1 Carnitine 1 Botulinum Toxins, Type A 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521826 2026-04-13

FITCAN

State University of Londrina

Phase NA Not yet recruiting

Muscular Atrophy, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡